Cardiac Marker Point-Of-Care Testing in the Emergency Department and Cardiac Care Unit (Beckman Conference) Cardiac Marker Point-Of-Care Testing in the Emergency Department and Cardiac Care Unit (Beckman Conference)

Cardiac Marker Point-Of-Care Testing in the Emergency Department and Cardiac Care Unit (Beckman Conference‪)‬

Clinical Chemistry 1998, August, 44, 8

    • €2.99
    • €2.99

Publisher Description

Four million chest pain patients are admitted each year for ruling out acute myocardial infarction (AMI). [1] Up to 70% of patients are admitted to the Cardiac Care Unit (CCU) for suspected AMI rule out (1), with estimates suggesting that two to three billion dollars per year could be saved caring for this population in a less intensive setting (2). However, AMI patients may present to the Emergency Department (ED) with normal or nondiagnostic electrocardiograms (ECGs) 50% of the time, making early diagnosis of AMI difficult (3). Up to 8% of AMI patients may be inadvertently discharged from the ED, and this subset of patients accounts for 20% of emergency medical malpractice dollar losses and leads to increased morbidity and mortality. (4, 5). Frequent misdiagnoses given to AMI patients inadvertently discharged from the ED include esophagitis, muscle strain, and exacerbation of chronic obstructive pulmonary disease. In a recent review of missed AMI closed malpractice claims, ~25% of missed AMI cases were because of ECG misinterpretation, in 25% of cases the ECG was correctly interpreted but the clinical importance of the ECG findings were not appreciated, and the remaining 50% had nondiagnostic ECGs and atypical symptom complexes (6).

GENRE
Science & Nature
RELEASED
1998
1 August
LANGUAGE
EN
English
LENGTH
16
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
189.5
KB

More Books by Clinical Chemistry

Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004